Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine

NCT02465476 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT02465476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02465476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine
Lead sponsor
University Hospital, Toulouse
Phase
Not applicable
Overall status
Completed
Start date
January 6, 2015
Completion date
May 30, 2018
Enrollment
212 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

skin disease